The economics of improving global infectious disease surveillance

Bibliographic Data

ID21880604
AuthorsLinda de Vries (0000-0002-7485-6202, Erasmus University Rotterdam, corresponding author), Marion Koopmans (0000-0002-5204-2312, Erasmus MC), Alec Morton (0000-0003-3803-8517, University of Strathclyde), Pieter Van Baal (0000-0001-9913-2393, Erasmus University Rotterdam)
Year2021
Volume6
Issue9
Pagese006597
Publication date2021-09-01
Open AccessYes
TypeARTICLE
VenueBMJ Global Health (JOURNAL)
Journal identifiersISSN: 2059-7908 • E-ISSN: 2059-7908
PublisherBMJ (PUBLISHER • GB)
DOI10.1136/bmjgh-2021-006597
PMID34475025
OpenAlexW3198151896
LanguageEN
Citations received2
References cited20

With the global increase in population density, urbanisation, and global travel and trade, the threat of widespread outbreaks of infectious diseases has increased relentlessly, 1 as evidenced by recent examples of COVID-19 and Ebola. Further, although the most important causes of death shifted to non-communicable diseases, in some poorer parts of the world, communicable diseases remain the most important cause of death.2 Crucial in the prevention of and reaction to these threats is early detection, which demands an infectious disease surveillance system that can signal unusual events. How to set up and improve surveillance and how to prioritise investments are questions that need input from different scientific discip

Communicable disease · Disease · Disease surveillance · Economic growth · Environmental health · Global health · Outbreak · Pandemic · Pathology · Population · Public health · Urbanization · Data-Driven Disease Surveillance · Immune responses and vaccinations · Medicine · Zoonotic diseases and public health · Virology

Tools

Open DOIOpen Access